{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:24:10Z","timestamp":1786123450225,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Guidelines for postoperative nausea and vomiting (PONV) prophylaxis in pediatric patients recommend escalation of the number of antiemetics based on a preoperative estimate of PONV risk. These recommendations have been translated into performance metrics, most notably by the Multicenter Perioperative Outcomes Group (MPOG), used at over 25 children\u2019s hospitals. The impact of this approach on clinical outcomes is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a single-center, retrospective study of pediatric general anesthetic cases from 2018 to 2021. PONV risk factors were defined using MPOG definitions: age \u22653 years, volatile use \u226530 minutes, PONV history, long-acting opioids, female \u226512 years, and high-risk procedure. Adequate prophylaxis was defined using the MPOG PONV-04 metric: 1 agent for 1 risk factor, 2 agents for 2 risk factors, and 3 agents for 3+ risk factors. PONV was defined as documented postoperative nausea\/emesis or administration of a rescue antiemetic. Given the nonrandomized allocation of adequate prophylaxis, we used Bayesian binomial models with propensity score weighting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>A total of 14,747 cases were included, with PONV in 11% (9% adequate prophylaxis versus 12% inadequate). Overall, there was evidence for reduced incidence of PONV with adequate prophylaxis: weighted median odds ratio 0.82 (95% credible interval, 0.66\u20131.02; probability of benefit, 0.97) and weighted marginal absolute risk reduction 1.3% (\u22120.1% to 3.1%). In unweighted estimates, there was an interaction between sum of risk factors and the association of adequate prophylaxis with PONV, with reduced incidence in patients with 1 to 2 risk factors (probability of benefit 0.96 and 0.95) but increased incidence in patients with 3+ risk factors receiving adequate prophylaxis (probability of benefit 0, 0.01, and 0.03 for 3, 4, and 5 risk factors). This was attenuated by weighting, with persistent benefit in 1 to 2 risk factors (probability of benefit 0.90 and 0.94) but equalization of risk in 3+ risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Guideline-directed PONV prophylaxis is inconsistently associated with incidence of PONV across the guideline-defined risk spectrum. This phenomenon, and its attenuation with weighting, is consistent with 2 points: dichotomous risk-factor summation ignores differential effects of individual components, and prognostic information might exist beyond these risk factors. PONV risk at a given sum of risk factors is not homogeneous, but rather is determined by the unique composition of risk factors and other prognostic attributes. These differences appear to have been identified by clinicians, prompting use of more antiemetics. Even after accounting for these differences, however, addition of a third agent did not further reduce risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006543","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T13:12:28Z","timestamp":1685106748000},"page":"144-154","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Association of Guideline-Directed Prophylaxis with Postoperative Nausea and Vomiting in Pediatric Patients: A Single-Center, Retrospective Cohort Study"],"prefix":"10.1213","volume":"139","author":[{"given":"Benjamin Y.","family":"Andrew","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Habib","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad M.","family":"Taicher","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40272-020-00424-0","article-title":"Postoperative nausea and vomiting in pediatric patients.","volume":"23","author":"Kovac","year":"2021","journal-title":"Paediatr Drugs"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bjae.2019.05.006","article-title":"Postoperative vomiting in children.","volume":"19","author":"Morrison","year":"2019","journal-title":"BJA Educ"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2044.2008.05438.x","article-title":"Paediatric day-case surgery: an audit of unplanned hospital admission royal hospital for sick children, Glasgow.","volume":"63","author":"Blacoe","year":"2008","journal-title":"Anaesthesia"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting.","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jclinepi.2004.08.010","article-title":"Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study.","volume":"58","author":"Sung","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R8-20250502","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights.","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/sim.8486","article-title":"Uncertainty in the design stage of two-stage Bayesian propensity score analysis.","volume":"39","author":"Liao","year":"2020","journal-title":"Stat Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1213\/01.ANE.0000135639.57715.6C","article-title":"The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients.","volume":"99","author":"Eberhart","year":"2004","journal-title":"Anesth Analg"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/pan.12428","article-title":"Development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients: the VPOP score.","volume":"24","author":"Bourdaud","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"A tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration.","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ALN.0b013e31818d6b26","article-title":"How much does pharmacologic prophylaxis reduce postoperative vomiting in children? Calculation of prophylaxis effectiveness and expected incidence of vomiting under treatment using Bayesian meta-analysis.","volume":"109","author":"Engelman","year":"2008","journal-title":"Anesthesiology"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1213\/ANE.0b013e3181bd1bce","article-title":"CON: postoperative nausea and vomiting database research: limitations and opportunities.","volume":"110","author":"Habib","year":"2010","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:13Z","timestamp":1786113133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006543","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}